Optimizing regulatory T cells for therapeutic application in human organ transplantation

Current Opinion in Organ Transplantation
Trishan VaikunthanathanGiovanna Lombardi

Abstract

Initial clinical trials of adoptive regulatory T-cell (Treg) therapy in solid organ transplantation have proven to be both feasible and well tolerated. With Phase 2 trials underway, efforts have been focused on the optimization of the Treg product. With science and our knowledge on the biology of these cells constantly advancing, we have been able to refine our search for a Treg population that would be ideally suited for therapeutic application. This idealized population must be readily isolated, allow for in-vitro expansion, demonstrate potent and specific suppressor function, maintain lineage stability and demonstrate a relevant homing profile. With the advent of innovative cell analysis/isolation techniques and genetic modifications, we are able to choose and design Tregs to fulfil these criteria. By utilizing advances in science and technology, we can optimize Treg therapy in human organ transplantation maximizing their prospects in the arena of transplantation tolerance.

References

Jan 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pengfei ZhouKenneth Croitoru
Jun 9, 2004·The Journal of Experimental Medicine·Qizhi TangJeffrey A Bluestone
Dec 4, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Ying LiKoichi Tanaka
Jan 18, 2005·Biochemical and Biophysical Research Communications·Byung-Min ChoiHun-Taeg Chung
Mar 5, 2005·Blood·Manuela BattagliaMaria-Grazia Roncarolo
Feb 1, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ahmet DemirkiranLuc J W van der Laan
Mar 1, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Petra HoffmannMatthias Edinger
Jul 5, 2006·The Journal of Experimental Medicine·Weihong LiuJeffrey A Bluestone
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keishi FujioKazuhiko Yamamoto
Dec 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Manuela BattagliaMaria-Grazia Roncarolo
Jan 11, 2007·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
Feb 15, 2007·PLoS Biology·Stefan FloessJochen Huehn
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dipica HaribhaiTalal A Chatila
Mar 17, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Alberto Sánchez-FueyoTerry B Strom
Jun 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xin ChenJoost J Oppenheim
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Richard J DiPaoloEthan M Shevach
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Oriol BestardJosep M Grinyó
Dec 11, 2007·Nature Medicine·Olivier JoffreJoost P M van Meerwijk
Oct 11, 2008·The Journal of Clinical Investigation·Julia Yuen-Shan TsangRobert Lechler
Dec 17, 2008·Diabetes·Amy L PutnamJeffrey A Bluestone
Mar 14, 2009·European Journal of Immunology·Petra HoffmannMatthias Edinger
Apr 8, 2009·European Journal of Immunology·Leigh A StephensStephen M Anderton
May 15, 2009·Proceedings of the National Academy of Sciences of the United States of America·Maha AyyoubDanila Valmori
Nov 4, 2009·Proceedings of the National Academy of Sciences of the United States of America·Graham P WrightHans J Stauss
Jun 19, 2010·Nature Reviews. Immunology·Shimon SakaguchiDavid A Hafler
Jan 27, 2011·Nature Reviews. Immunology·Daniel J Campbell, Meghan A Koch
Mar 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Donald B KohnHelen E Heslop
Mar 4, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie A McClymontTodd M Brusko
May 5, 2011·Nature Medicine·Margarita Dominguez-VillarDavid A Hafler
May 14, 2011·Haematologica·Eleonora TresoldiManuela Battaglia
Jun 10, 2011·The Journal of Investigative Dermatology·H Jorn BovenschenHans J P M Koenen
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Sep 29, 2011·Blood·Anandharaman VeerapathranClaudio Anasetti
Nov 4, 2011·The New England Journal of Medicine·Antonio Di StasiMalcolm K Brenner
Jul 14, 2012·Current Opinion in Organ Transplantation·Qizhi Tang, Karim Lee

❮ Previous
Next ❯

Citations

Dec 10, 2020·Science Signaling·Heather TorreyDenise L Faustman
Aug 11, 2021·European Journal of Immunology·Niloufar SafiniaGiovanna Lombardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Related Papers

Clinical and Experimental Immunology
Trishan VaikunthanathanGiovanna Lombardi
Current Opinion in Organ Transplantation
N SafiniaGiovanna Lombardi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Allison L BayerC Cabello-Kindelan
© 2022 Meta ULC. All rights reserved